TXMD (STOCKS)
TherapeuticsMD, Inc.
$2.050000
-0.020000 (-0.97%)
Prev close: $2.070000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Marlan D. Walker
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $23.61M
- Employees
- 1
- P/E (TTM)
- -41.58
- P/B (TTM)
- 0.89
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $3.02M |
| Benefits Costs and Expenses | $3.68M |
| Costs And Expenses | $3.68M |
| Nonoperating Income/Loss | $3.74M |
| Operating Expenses | $7.41M |
| Depreciation and Amortization | $384.00K |
| Other Operating Expenses | $7.03M |
| Operating Income/Loss | -$4.39M |
| Income/Loss From Continuing Operations After Tax | -$653.00K |
| Income/Loss From Continuing Operations Before Tax | -$653.00K |
| Income/Loss From Discontinued Operations Net Of Tax | $84.00K |
| Net Income/Loss | -$569.00K |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$569.00K |
| Net Income/Loss Available To Common Stockholders, Basic | -$569.00K |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.05 |
| Diluted Earnings Per Share | -$0.05 |
| Basic Average Shares | 11,569,000 |
| Diluted Average Shares | 11,569,000 |
| Assets | $37.66M |
| Current Assets | $14.45M |
| Noncurrent Assets | $23.21M |
| Intangible Assets | $3.76M |
| Other Non-current Assets | $19.45M |
| Liabilities | $10.78M |
| Current Liabilities | $4.79M |
| Accounts Payable | $377.00K |
| Wages | $310.00K |
| Other Current Liabilities | $4.10M |
| Noncurrent Liabilities | $6.00M |
| Equity | $26.88M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $26.88M |
| Liabilities And Equity | $37.66M |
| Net Cash Flow From Operating Activities | $2.42M |
| Net Cash Flow From Operating Activities, Continuing | $2.45M |
| Net Cash Flow From Operating Activities, Discontinued | -$30.00K |
| Net Cash Flow | $2.42M |
| Net Cash Flow, Continuing | $2.45M |
| Net Cash Flow, Discontinued | -$30.00K |
| Comprehensive Income/Loss | -$569.00K |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$569.00K |
| Other Comprehensive Income/Loss | $0.00 |